UroToday
TRUS-guided prostate biopsy, prostate cancer diagnosis, transperineal needle biopsy guided by digital palpation per rectum, PSMA-targeted PET/CT, fluciclovine-PET/CT in patients with biochemical recurrence.
TRUS-guided prostate biopsy, prostate cancer diagnosis, transperineal needle biopsy guided by digital palpation per rectum, PSMA-targeted PET/CT, fluciclovine-PET/CT in patients with biochemical recurrence.
FDA clearance for Gynethotics™ Pessaries, Gynethotics™, Cosm Medical, advancement in pelvic care, benefits of personalized Gynethotics™ Pessaries, precision care into gynecology.
Cohort 3 of the theranostic SECuRE trial, Clarity’s Theranostic Prostate Cancer Trial, 64Cu/67Cu-SAR-bisPSMA, metastatic castrate-resistant prostate cancer (mCRPC), Clarity Pharmaceuticals.
At the 2024 UCSF-UCLA PSMA Conference, Thomas Hope explores the impact of PSMA PET imaging on prostate cancer care, emphasizing the ProPSMA trial’s comparison of…
5-Alpha Reductase Inhibitors, Benign prostatic hyperplasia (BPH), bladder cancer, α-B therapy, Alpha-Blockers (α-B), IBM® MarketScan® Research de-identified Databases across the United States.
Asmaa El-Kenawi discusses her group’s research on therapeutic resistance in cancer, particularly focusing on the role of methionine in driving resistance. Published in “Cancer Research,”…
Pedro Barata and David Braun delve into the evolving landscape of biomarkers in renal cell carcinoma (RCC). Dr. Braun emphasizes the transition from histological analysis…
bladder cancer, Bladder Sarcoma, sarcoma of the urinary bladder (SUB), Retroperitoneal sarcomas (RPS), Rare Cancer Network, primary sarcoma of the urinary bladder, urothelial carcinoma (UC)…
prostate cancer, metastatic hormone sensitive prostate cancer (mHSPC), androgen deprivation therapy (ADT), apalutamide, enzalutamide, Current State of Treatment Implementation for Metastatic Hormone Sensitive Prostate Cancer,…
Urinary Tumor DNA for the Detection of Field Cancerization, urinary tumor DNA (utDNA), non-muscle invasive bladder cancer (NMIBC), TP53, STAG2, ARID1A, high-grade recurrence-free survival (HG-RFS),…
Program: Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC Part of an Independent Medical Education Initiative Supported by LOXO@Lilly Biographies:…